1.Effects of Losartan on Heart Rate Variability of Essential Hypertensive Patients
Jien PANG ; Feng CHEN ; Guangzhi SU ; Jian MA
China Pharmacy 2001;0(08):-
OBJECTIVE:To study the effect of losartan on heart rate variability of essential hypertensive patientsMETHO_DS:The heart rate power spectral density and time-domain in 24-hour dynamic EKG were analyzed in 50 healthy subjects and in 90 patients with hypertension before and after giving losartanRESULTS:The low frequency and total frequency and ratio between low frequency and high frequency of hypertensive patients were significantly higher than those of controls,the high frequency and standard deviation of normal-to-normal intervals(SDNN) and standard deviation of the average of RR intervals(SDANN) for each five-minute period of the 24-hour eletrocardiographic recordings were significantly lower than those of controlsThe SDNN and high frequency of grade Ⅲ hypertension were significantly lower than those of grade Ⅱ hypertensionThe low frequency and ratio between low frequency and high frequency of grade Ⅲ hypertension were significantly higher than those of grade Ⅱ hypertension,and so were the grade Ⅱ than those of the grade Ⅰ It showed that vegetative nerve functi_onal damage was positively related with hypertensive gradeThe severer the illness,the greater the changeAfter losartan treatment,in addition to lowing the blood pressure,the SDNN,SDANN and high frequency of hypertensive patients were significantly increasedThe low frequency,total frequency and ratio between low frequency and high frequency of hypertensive patients were significantly decreasedCONCLUSION:When losartan lowers blood pressure,it can significantly improve the heart rate variability of essential hypertensive patients
2.Development and biomechanical evaluation of a model of lumbar interbody fusion device
Jinliang MA ; Jien ZHANG ; Kebin LIU ; Yang YI ; Fan HUANG ; Zhongliang DENG
Chongqing Medicine 2014;(4):465-468
objective To introduce the design concept and structure of a new type of lumbar intervertebral fusion cage ,and to e-valuate its biomechanical properties .Method A partially bioasorbable interbody fusion cage(PBIFC) made of nano hydroxyapatite and poly amino acid /calcium sulfate copolymer materials was developed .Range of motion(ROM ) ,compressive load ,and pull-out test on flexion ,extension ,lateral bending ,and torsion moment on fresh calf L3/L4 specimens of functional spinal union were carried out of iliac bone group ,PBIFC group ,and nano hydroxyapatite/polyamide 66(nHA/PA66) group .Result Of each movement ,the ROM value of iliac bone group are higher than the other two groups ,the difference was statistically significant (P<0 .05) ,and the ROM value of nHA/PA66 group are higher than PBIFC group ,but no statistical difference(P>0 .05) .The pull-out strength of PB-IFC group are higher than iliac bone group ,and the difference was statistically significant (P<0 .05);The pull-out strength of PB-IFC group is lower than the traditional group ,but no statistical difference(P>0 .05) .The compressive load of iliac bone group was lower than that of two cage group ,the difference was statistically significant (P<0 .05) .The compressive load of PBIFC group is slightly lower than the traditional group ,but no statistical difference(P>0 .05) .Conclusion With good implant stability ,pull-out resistance ,and compression resistance performance ,PBIFC can meet the biomechanics requirements of clinical implant .
3.Intervention effect of Xuebijing injection on coagulation function of patients with severe sepsis
Ruiying GONG ; Minghui TIE ; Weiyi GONG ; Lin SHEN ; Yongcheng PANG ; Jien MA
Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 2018;25(3):254-256
Objective To observe the effect of Xuebijing on coagulation function in patients with sepsis. Methods Sixty-two patients with severe sepsis were admitted to Department of Emergency and Intensive Care Unit (ICU) of Kunming Municipal Hospital of Traditional Chinese Medicine from February 2015 to June 2017, and they were divided into Xuebijing group and routine treatment control group according to the random number table method, 31 cases in each group. Both groups were treated with symptomatic supportive therapy, and the Xuebijing group was treated with Xuebijing injection 50 mL intravenous drip on the basis of routine treatment, twice a day for consecutive 7 days. The differences in platelet count (PLT), 5 items of coagulation: D-dimer, fibrinogen (Fib), activated partial thromboplastin time (APTT), prothrombin time (PT), thrombin time (TT) and acute physiology and chronic health evaluationⅡ (APACHE Ⅱ) score were compared between the two groups before and after treatment. Results After treatment, in both groups, the levels of PLT and Fib were significantly higher than those before treatment, the level of D-dimer, APACHE Ⅱ were obviously lower than those before treatment, APTT, PT and TT were significantly shorter than those before treatment, and the changes in Xuebijing group were more marked than those in the routine treatment control group [PLT (×109/L):186.63±45.29 vs. 119.96±59.76, Fib (g/L): 3.88±1.82 vs. 2.33±1.33, D-dimer (mg/L): 0.40±0.11 vs. 0.65±0.14, APTT (s): 30.95±8.48 vs. 42.25±7.73, PT (s): 10.97±1.51 vs. 13.16±2.22, TT (s): 16.17±1.28 vs. 18.98±1.12, APACHE Ⅱ score: 6.62±2.91 vs. 12.87±4.54, all P < 0.05]. Conclusion Xuebijing can regulate coagulation disorder in patients with severe sepsis, ameliorate the disease condition of patients, block the deterioration of disease development, and improve the prognosis of patients.